Back

Global X Enhanced All-Equity Asset Allocation ETF Vs. Jazz Pharmaceuticals Plc Industry Stock Comparison

Sell

HEQL.TO
Global X Enhanced All-Equity Asset Allocation ETF

Last Price:

$33.26

Seasonality Move:

-1.39%

Buy

JAZZ
Jazz Pharmaceuticals Plc

Last Price:

$186.87

Seasonality Move:

15.66%

Sell

Global X Enhanced All-Equity Asset Allocation ETF (HEQL.TO) is a Sell

Is Global X Enhanced All-Equity Asset Allocation ETF a Buy, Sell or Hold?

The current Global X Enhanced All-Equity Asset Allocation ETF [HEQL.TO] share price is $33.29. The Score for HEQL.TO is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
HEQL.TO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

Buy

Jazz Pharmaceuticals Plc (JAZZ) is a Buy

Is Jazz Pharmaceuticals Plc a Buy, Sell or Hold?

The current Jazz Pharmaceuticals Plc [JAZZ] share price is $186.95. The Score for JAZZ is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
JAZZ is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

HEQL.TO Stock Price Chart

What is Global X Enhanced All-Equity Asset Allocation ETF's stock price today?

The Global X Enhanced All-Equity Asset Allocation ETF share price today is $33.29

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and HEQL.TO is experiencing buying pressure, which is a positive indicator for future bullish movement.

JAZZ Stock Price Chart

What is Jazz Pharmaceuticals Plc's stock price today?

The Jazz Pharmaceuticals Plc share price today is $186.95

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and JAZZ is experiencing slight buying pressure.

HEQL.TO Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	7.31	Buy
Relative Strength Index (14 RSI):	52.17	Buy
Chaikin Money Flow:	10186	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(32.24 - 33.86)	Buy
Bollinger Bands (100):	(32.69 - 34.39)	Sell

JAZZ Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	2.46	Buy
Relative Strength Index (14 RSI):	56.41	Buy
Chaikin Money Flow:	99997	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(181.31 - 188.21)	Buy
Bollinger Bands (100):	(159.39 - 183.63)	Buy

HEQL.TO Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	32.57	Buy
20-day SMA:	32.74	Buy
50-day SMA:	33.73	Sell
200-day SMA:	32.17	Buy
8-day EMA:	32.15	Buy
20-day EMA:	26.05	Buy
50-day EMA:	15.42	Buy
200-day EMA:	4.82	Buy

JAZZ Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	186.67	Buy
20-day SMA:	183.98	Buy
50-day SMA:	177.12	Buy
200-day SMA:	147.45	Buy
8-day EMA:	186.19	Buy
20-day EMA:	184.12	Buy
50-day EMA:	178.58	Buy
200-day EMA:	155.1	Buy

Global X Enhanced All-Equity Asset Allocation ETF Earnings Growth & HEQL.TO Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Jazz Pharmaceuticals Plc Earnings Growth & JAZZ Earnings Dates

Analysts estimate an earnings increase this quarter of $0.45 per share, a decrease next quarter of $1.59 per share, an increase this year of $15.74 per share, and an increase next year of $1.01 per share.

Global X Enhanced All-Equity Asset Allocation ETF Technical Analysis

	Mar 20	Mar 23	Mar 24	Mar 25	Mar 26	Mar 27	Mar 30	Mar 31	Apr 1	Apr 2
	Mar									Apr
	20	23	24	25	26	27	30	31	01	02
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Jazz Pharmaceuticals Plc Technical Analysis

	Mar 20	Mar 23	Mar 24	Mar 25	Mar 26	Mar 27	Mar 30	Mar 31	Apr 1	Apr 2
	Mar									Apr
	20	23	24	25	26	27	30	31	01	02
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):